Piscicolin 126 is a class IIa bacteriocin isolated from Carnobacterium piscicola JG126 that exhibits strong activity against Listeria monocytogenes. The gene encoding mature piscicolin 126 (m-pisA) was cloned into an Escherichia coli expression system and expressed as a thioredoxin-piscicolin 126 fusion protein that was purified by affinity chromatography. Purified recombinant piscicolin 126 was obtained after CNBr cleavage of the fusion protein followed by reversed-phase chromatography. Recombinant piscicolin 126 contained a single disulfide bond and had a mass identical to that of native piscicolin 126. This novel bacteriocin expression system generated approximately 26 mg of purified bacteriocin from 1 liter of E. coli culture. The purified recombinant piscicolin 126 acted by disruption of the bacterial cell membrane.Bacteriocins produced by lactic acid bacteria (LAB) have been classified into four classes (23). The class II bacteriocins, which are small (Ͻ10 kDa), heat-stable, non-lanthionine-containing, and membrane-active amphipathic peptides, have been further divided into three groups on the basis of their sequence homology and mechanism of action (23, 29). The class IIa bacteriocins from the LAB are active against Listeria and contain an N-terminal consensus sequence of YGNGV. The antibacterial activity, mechanism of action, and structurefunction relationships of class IIa bacteriocins have been investigated with a view to their development and application in the targeted prevention of growth of human pathogens in food. Class IIa bacteriocins are active at the cell membranes of gram-positive organisms, and their limited spectrum of activity is attributed to the requirement for a specific receptor interaction on the target cell (11,12,16,17,34,38). Class IIa bacteriocins cause the efflux of accumulated compounds and ions (1,5,8,25,39), a dissipation of the membrane potential (1), and depletion of ATP (8), thereby preventing growth of the organism.A requirement for the continued improvement of structurefunction models of class IIa bacteriocins through biophysical studies is the production and purification of large quantities (up to 10 mg) of bacteriocin. Bacteriocin production systems currently utilized include expression in the native strain (19,21), recombinant expression systems in LAB (3, 24), recombinant expression by use of Escherichia coli (27,28), and chemical synthesis (15, 37). The utilization of recombinant expression systems permits the generation of fusion proteins or incorporation of affinity tags that improve purification. Chemical synthesis of class IIa bacteriocins produced large amounts (1 g) of biologically active bacteriocin (15, 37); however, the low purity of the chemically synthesized material resulted in a less-efficient bacteriocin production system. In vitro translation systems for the production of bacteriocins can also be applied. However, a problem with both chemical synthesis and in vitro translation systems is the requirement to form intramolecular disulfide bonds to produce...